Skip to main content
An official website of the United States government

Gastrointestinal and Other Cancers

Conducts and supports prevention and early detection research for colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers. Supports development of new approaches for clinical prevention studies, including cancer immunoprevention.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Della'Zanna, Gary, D.O., M.Sc.
gary.dellazanna@nih.gov
240-276-7042
5E234 Program Officer | Gastrointestinal and Other Cancers
Garvey, Rodshae
garveyrj@nih.gov
240-276-5764
5E220 Program Support Assistant | Gastrointestinal and Other Cancers
Program Support Assistant | Lung and Upper Aerodigestive Cancer
Rodriguez, Luz Maria, M.D., FACS
luz.rodriguez@nih.gov
240-276-7039
5E228 Program Officer | Gastrointestinal and Other Cancers
Umar, Asad, D.V.M., Ph.D.
asad_umar@nih.gov
240-276-7038
5E226 Chief | Gastrointestinal and Other Cancers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Forsberg, Flemming

Thomas Jefferson University
United States

Prostate Cancer Diagnosis by Multiparametric Ultrasound 5R01CA252311-05
Frazier, Anne Lindsay

Dana-Farber Cancer Inst
United States

Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-05 Nicholas Hodges, Ph.D.
Freedland, Stephen Jay

Cedars-Sinai Medical Center
United States

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes 3R01CA280081-03S1 Young Kim, Ph.D.
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 3UG1CA189812-11S1 Vanessa A. White, M.P.H.
Furuta, Saori

Case Western Reserve University
United States

Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer 5R01CA248304-05
Fuschiotti, Patrizia

University Of Pittsburgh At Pittsburgh
United States

Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 5R21CA280445-02 Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-02 Marjorie Perloff, M.D.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-04 Asad Umar, D.V.M., Ph.D.
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. 5R21CA270702-02 Marjorie Perloff, M.D.
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer 1R01CA301372-01 Anda Vlad, M.D., Ph.D.
Ghamande, Sharad A.

Augusta University
United States

Georgia CaRes 3UG1CA189851-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Myeloma multidimensional precancer atlas 4U01CA294507-02 Nicholas Hodges, Ph.D.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Molecular prediction of myeloma in African Americans 5U01CA271492-04 Claire Zhu, Ph.D.
Ghosh, Jayashri

Temple Univ Of The Commonwealth
United States

Development of blood-based methylation biomarkers for CRC risk prediction 5R01CA281948-03 Matthew Young, Ph.D.
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-02 Marjorie Perloff, M.D.